Source comparison
Comparison: TB-500 vs Growth Hormone for Injury Recovery
Mechanism Actin-binding, angiogenesis, VEGF upregulation Systemic collagen synthesis, IGF-1 stimulation, protein synthesis Direct IGF-1 receptor activation, localized hypertrophy and repair TB-500 is tissue-specific; GH is systemic but slower; IGF-1 is localiz
This comparison does not assign a generated winner or score.
- Mechanism
- Actin-binding, angiogenesis, VEGF upregulation
- Systemic collagen synthesis, IGF-1 stimulation, protein synthesis
- Direct IGF-1 receptor activation, localized hypertrophy and repair
- TB-500 is tissue-specific; GH is systemic but slower; IGF-1 is localized but carries hyperplasia risk
- Time to Symptom Relief
- 2–3 weeks
- 4–8 weeks
- 1–2 weeks
- TB-500 middle-ground between IGF-1 speed and GH safety profile
- Cost (4-week protocol)
- $120–$200
- $400–$800
- $180–$300
- TB-500 most cost-effective for targeted tendon repair
- Injection Frequency
- Daily or every other day
- TB-500 least burdensome for compliance
- Primary Use in Powerlifting
- Chronic tendinopathy, ligament inflammation
- Systemic recovery, multiple injury sites, anti-aging
- Acute muscle belly tears, localized hypertrophy during recovery
- TB-500 wins for single-site tendon issues; GH for systemic recovery; IGF-1 for muscle-specific damage
- Regulatory Status
- Research peptide, not FDA-approved for human use
- Prescription required (FDA-approved for growth hormone deficiency)
- All three exist outside FDA approval for performance or injury enhancement in healthy adults
- Growth hormone promotes collagen synthesis systemically, which benefits connective tissue repair, but the timeline is slower than TB-500's targeted angiogenesis. Powerlifters using 2–4 IU GH daily report improved recovery across multiple injury sites, but the cost ($400–$800 per month) and daily injection requirement make it impractical for single-tendon issues. TB-500 provides comparable tendon-specific benefit at one-third the cost with half the injection frequency.
- IGF-1 LR3 (Long R3 Insulin-Like Growth Factor-1) accelerates localized repair faster than TB-500 but carries hyperplasia risk. Uncontrolled cell proliferation that can worsen scar tissue formation if used improperly. Competitive lifters reserve IGF-1 for acute muscle belly tears where rapid hypertrophy aids recovery, not for tendon issues where controlled collagen remodeling is the priority.